scPharmaceuticals -ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates

ScPharmaceuticals, Inc. (SCPH) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of$ 0.30. This compares to loss of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -23.33%. A quarter ago, it was expected that this company would post a loss of$ 0.44 per share when it actually produced a loss of $0.44, delivering no surprise.Over the last four quarters, the company has surpasse ...